Deprecated: Return type of Requests_Cookie_Jar::offsetExists($key) should either be compatible with ArrayAccess::offsetExists(mixed $offset): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/finbold-prod/ on line 63
Skip to content
CRL Charles River Laboratories International Inc NYSE
192.92 USD -0.33% -0.64
OPEN 191.28
DAY RANGE 193.37 - 188.86
52 WEEK RANGE 308.15 - 181.36
Interactive Brokers Logotype

Buy CRL stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 9.9B
Enterprise value 12.8B
Trailing pe 21.652077
Forward pe 15.710098
Peg ratio 15.710098
Price to sales ttm 2.4820461
Price to book mrq 3.302124
Enterprise to revenue 3.218
Enterprise to ebitda 13.297


Fiscal year ends 2022-12-31
Most recent quarter 2022-12-31
Profit margin 0.12229
Operating margin 0.16562
Return on assets ttm 0.05628
Return on equity ttm 0.17544001
Income statement
Revenue ttm 4B
Revenue per share ttm 78.25
Quarterly revenue growth 0.215
Gross profit ttm 1.5B
Ebitda 1B
Net income to common ttm 486.2M
Diluted eps ttm 8.91
Quarterly earnings growth yoy 0.362
Balance sheet
Total cash mrq 233.9M
Total cash per share mrq 4.588
Total debt mrq 3.1B
Total debt to equity mrq 104.1
Current ratio mrq 1.318
Book value per share mrq 58.423
Cash flow
Operating cash flow ttm 619.6M
Levered free cash flow ttm 299.3M

Stock statistics

Shares outstanding 51M
Float shares 50.4M
Avg 10 volume 689.9K
Avg 30 volume 663.5K
Shares short 1.3M
Short ratio 2.04
Short percent of shares outstanding 0.0332
Percent held by insiders 0.010290001
Percent held by institutions 0.99017

Stock price summary

Fifty two week low 181.36
Fifty two week high 308.15
Fifty two week change -48.564
Beta 1.359172
Day 50 ma 232.975
Day 200 ma 221.6955

Dividends and splits

Charles River Laboratories International (CRL) company profile

Charles River Laboratories International Inc. (NYSE: CRL) is a contract research company that offers products and services to enable pharmaceutical and biotechnology companies, government agencies, and academic institutions to conduct research in drug development. The company also offers safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The company’s services are through the segments of Discovery and Safety Assessment and Manufacturing Solutions.